New diabetes clinical trial: TRIgyceride And Glucose Control With Epeleuton in Metabolic Syndrome Patients

Published on: April 28, 2020 at 09:30PM
Conditions:   Hypertriglyceridemia;   Type 2 Diabetes
Interventions:   Drug: DS102;   Drug: Placebo
Sponsor:   Afimmune
Not yet recruiting
https://ift.tt/35ejSGI